FDA Includes Device Scenarios in GMP Guidance for Combo Products

The GMP Letter
The FDA’s recently released final guidance on GMP requirements for combination products includes several compliance scenarios for prefilled syringes, drug-coated meshes and drug-eluting stents.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00